A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury

Argon (Ar) is a noble gas with known organoprotective effects in rodents and in vitro models. In a previous study we failed to find a postconditioning effect of Ar during ex vivo lung perfusion (EVLP) on warm-ischemic injury in a porcine model. In this study, we further investigated a prolonged exposure to Ar to decrease cold ischemia-reperfusion injury after lung transplantation in a porcine model with EVLP assessment. Domestic pigs (n = 6/group) were pre-conditioned for 6 hours with 21% O 2 and 79% N 2 (CONTR) or 79% Ar (ARG). Subsequently, lungs were cold flushed and stored inflated on ice for 18 hours inflated with the same gas mixtures. Next, lungs were perfused for 4 hours on EVLP (acellular) while ventilated with 12% O 2 and 88% N 2 (CONTR group) or 88% Ar (ARG group). The perfusate was saturated with the same gas mixture but with the addition of CO 2 to an end-tidal CO 2 of 35-45 mmHg. The saturated perfusate was drained and lungs were perfused with whole blood for an additional 2 hours on EVLP. Evaluation at the end of EVLP did not show significant effects on physiologic parameters by prolonged exposure to Ar. Also wet-to-dry weight ratio did not improve in the ARG group. Although in other organ systems protective effects of Ar have been shown, we did not detect beneficial effects of a high concentration of Ar on cold pulmonary ischemia-reperfusion injury in a porcine lung model after prolonged exposure to Ar in this porcine model with EVLP assessment.

[1]  Filip Rega,et al.  Machine perfusion of thoracic organs. , 2018, Journal of thoracic disease.

[2]  G. Verleden,et al.  Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  R. Rossaint,et al.  Beneficial Properties of Argon After Experimental Subarachnoid Hemorrhage: Early Treatment Reduces Mortality and Influences Hippocampal Protein Expression* , 2016, Critical care medicine.

[4]  Hailin Zhao,et al.  Argon protects against hypoxic-ischemic brain injury in neonatal rats through activation of nuclear factor (erythroid-derived 2)-like 2 , 2016, Oncotarget.

[5]  J. Pype,et al.  Argon and xenon ventilation during prolonged ex vivo lung perfusion. , 2016, The Journal of surgical research.

[6]  X. Golay,et al.  Inhaled 45–50% argon augments hypothermic brain protection in a piglet model of perinatal asphyxia , 2016, Neurobiology of Disease.

[7]  R. Guieu,et al.  Effectiveness of pure argon for renal transplant preservation in a preclinical pig model of heterotopic autotransplantation , 2016, Journal of Translational Medicine.

[8]  U. Goebel,et al.  Argon: a novel therapeutic option to treat neuronal ischemia and reperfusion injuries? , 2015, Neural regeneration research.

[9]  G. Verleden,et al.  A decade of extended‐criteria lung donors in a single center: was it justified? , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  S. Keshavjee,et al.  Extending the donor pool: rehabilitation of poor organs. , 2015, Thoracic surgery clinics.

[11]  C. Niemann,et al.  Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. , 2015, The New England journal of medicine.

[12]  R. Rossaint,et al.  Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage , 2015, Neurocritical Care.

[13]  R. Rossaint,et al.  Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by K(ATP)-channel opening. , 2014, Resuscitation.

[14]  G. Verleden,et al.  The site and nature of airway obstruction after lung transplantation. , 2014, American journal of respiratory and critical care medicine.

[15]  Xuejun Sun,et al.  Bustling argon: biological effect , 2013, Medical gas research.

[16]  O. Thom,et al.  Inflammatory Signalling Associated with Brain Dead Organ Donation: From Brain Injury to Brain Stem Death and Posttransplant Ischaemia Reperfusion Injury , 2013, Journal of transplantation.

[17]  A. Haverich,et al.  Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients , 2012, The Lancet.

[18]  M. Vizcaychipi,et al.  The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats* , 2012, Critical care medicine.

[19]  J. Risso,et al.  Ex Vivo and In Vivo Neuroprotection Induced by Argon When Given after an Excitotoxic or Ischemic Insult , 2012, PloS one.

[20]  Rolf Rossaint,et al.  The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. , 2012, European journal of pharmacology.

[21]  J. Pype,et al.  Noble Gas (Argon and Xenon)-Saturated Cold Storage Solutions Reduce Ischemia-Reperfusion Injury in a Rat Model of Renal Transplantation , 2012, Nephron Extra.

[22]  G. Verleden,et al.  Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  R. Rossaint,et al.  Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats* , 2011, Critical care medicine.

[24]  B. Meiser,et al.  Defining an extended criteria donor lung: an empirical approach based on the Eurotransplant experience 1 , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[25]  P. Pagel Cardioprotection by noble gases. , 2010, Journal of cardiothoracic and vascular anesthesia.

[26]  R. Rossaint,et al.  Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury , 2009, Critical care.

[27]  Kyle R. Eberlin,et al.  Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury. , 2008, Surgery.

[28]  P. Corris,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  G. Verleden,et al.  Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  Stephen E Kimmel,et al.  The effect of primary graft dysfunction on survival after lung transplantation. , 2005, American journal of respiratory and critical care medicine.

[31]  J. Kirby,et al.  Pulmonary Transplantation: the role of brain death in donor lung injury , 2003, Transplantation.

[32]  S. Keshavjee,et al.  Ischemia-reperfusion-induced lung injury. , 2003, American journal of respiratory and critical care medicine.

[33]  S. Steen,et al.  Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.

[34]  T. Marx,et al.  Xenon: Uptake and Costs , 2001, International anesthesiology clinics.